Mitochondria are exploited in cancer for tumor cell motility and metastatic competence

July 7, 2016, The Wistar Institute
Mitochondria. Credit: Wikipedia commons

As the powerhouse of the cells, mitochondria are critical for every organism because of their role in producing energy while also controlling survival, but how they function in cancer is still not completely known. This is particularly important because, in general, tumor cells proliferate more than normal tissues, and scientists have speculated that mechanisms that preserve mitochondrial function are responsible for supporting tumor expansion.

Now, scientists at The Wistar Institute have identified a specific network of proteins present in mitochondria of that is essential for maintaining a clean function of mitochondria, enabling not only the proliferation of tumor cells but also their ability to move and invade distant organs. By understanding the players involved, Wistar scientists were able to turn off individual subunits within the network, which greatly reduced the ability of to grow and spread, suggesting an attractive new therapeutic target. The findings were published in the journal PLOS Biology.

"This is an example of how tumors can quickly adapt to cope with their own higher biosynthetic needs," said Dario C. Altieri, M.D., President and CEO of The Wistar Institute, director of The Wistar Institute Cancer Center, the Robert & Penny Fox Distinguished Professor, and lead author of the study. "Mitochondria play a crucial role in a tumor's ability to process the energy needed to grow and spread, so identifying the mechanisms of how tumors maintain the function of mitochondria and exploit it to support abnormal cell proliferation and metastatic spread may uncover new therapeutic targets in a wide variety of cancers."

Prior studies provided evidence that the ability to control the folding and stability of proteins, or proteostasis, was important to reduce cellular stress. It has also been known that tumors hijack mechanisms of proteostasis to their advantage, but how this happened in mitochondria had remained largely unknown. The network described by the Wistar scientists answers this question and confirmed its important role in tumor development. In particular, one of the components of this network - ClpP - was found universally overexpressed in primary and metastatic human cancer and correlates to shortened patient survival. In this study alone, the scientists identified overexpression of this subunit in breast, prostate, colon and lung cancers as well as melanoma and lymphoma.

"There's quite a bit of interest in targeting pathways involved in function, and we've identified one such pathway that may provide a 'drugable' target for a variety of cancers," said Jae Ho Seo, Ph.D., a postdoctoral fellow in the Altieri lab at Wistar and first author of the study. "Other studies have shown that it is feasible to target mitochondrial proteins in preclinical models, so disrupting the network we identified in this study could shut off key processes that lead to tumor progression."

Explore further: Treatment with PI3K inhibitors may cause cancers to become more aggressive and metastatic

More information: PLOS Biology, DOI: 10.1371/journal.pbio.1002507

Related Stories

Treatment with PI3K inhibitors may cause cancers to become more aggressive and metastatic

June 29, 2015
The enzyme phosphatidylinositol-3 kinase (PI3K) appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target, with many PI3K-inhibiting drugs currently ...

'Rewired' mice show signs of longer lives with fewer age-related illnesses

July 31, 2014
While developing a new cancer drug, researchers at The Wistar Institute discovered that mice lacking a specific protein live longer lives with fewer age-related illnesses. The mice, which lack the TRAP-1 protein, demonstrated ...

Protein in metabolic reprogramming restrains senescent cells from becoming cancerous

April 30, 2015
In recent years, research has shown that cancerous cells have a different metabolism—essential chemical and nutritional changes needed for supporting the unlimited growth observed in cancer—than normal cells. Now, scientists ...

Team finds mitochondrial stress induces cancer-related metabolic shifts

July 6, 2016
Cancerous tumors must be fed. Their unregulated growth requires a steady stream of blood flow and nutrients. Thus, one way that researchers have tried to wipe out cancer is to target cells undergoing the metabolic shifts ...

Exploiting the stress response to detonate mitochondria in cancer cells

April 19, 2011
Researchers at The Wistar Institute have found a new way to force cancer cells to self-destruct. Low doses of one anti-cancer drug currently in development, called Gamitrinib, sensitize tumor cells to a second drug, called ...

Recommended for you

Single-cell study in a childhood brain tumor affirms the importance of context

April 20, 2018
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.

Aggressive breast cancer already has resistant tumour cells prior to chemotherapy

April 20, 2018
Difficult to treat and aggressive "triple-negative" breast cancer is chemoresistant even before chemotherapy begins, a new study by researchers from Karolinska Institutet and the University of Texas MD Anderson Cancer Center ...

Mechanism that drives development of liver cancer brought on by non-alcoholic fatty liver disease discovered

April 19, 2018
A team of researchers from several institutions in China has found a mechanism that appears to drive the development of a type of liver cancer not caused by alcohol consumption. In their paper published in the journal Science ...

Discovery adds to evidence that some children are predisposed to develop leukemia

April 19, 2018
St. Jude Children's Research Hospital researchers have made a discovery that expands the list of genes to include when screening individuals for possible increased susceptibility to childhood leukemia. The finding is reported ...

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

April 19, 2018
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that procedure, doctors insert a bone-biopsy needle through an ...

Scientists identify 170 potential lung cancer drug targets using unique cellular library

April 19, 2018
After testing more than 200,000 chemical compounds, UT Southwestern's Simmons Cancer Center researchers have identified 170 chemicals that are potential candidates for development into drug therapies for lung cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.